COVID-19: Genomic Surveillance Key to Mitigation and Containment
To recover from the COVID-19 pandemic, genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Covid 19 |
To recover from the COVID-19 pandemic, genomic surveillance is emerging as a vital necessity to achieve effective mitigation and containment.
Read MorePosted by Chris Wolski | Aug 20, 2021 | Covid 19, POC Instruments |
In a real-world test, self-collected COVID saliva samples provided comparable results to NP tests by trained healthcare professionals.
Read MorePosted by Chris Wolski | Aug 19, 2021 | Cancer |
llumina, Inc. has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers.
Read MorePosted by Chris Wolski | Aug 19, 2021 | Kidney Disease |
Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a protein in the urine test.
Read MorePosted by Chris Wolski | Aug 19, 2021 | Covid 19 |
The failure to contain COVID-19 was a result of a combination of factors, including outdated reporting and the rise of the Delta variant.
Read More